Boston, MA, United States of America

Stephan Kissler

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Joslin Diabetes Center, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephan Kissler. Retrieved from https://idiyas.com/inventor/stephan-kissler-2sr0cok8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephan Kissler

Introduction

Stephan Kissler is an accomplished inventor based in Boston, MA. He has made significant contributions to the field of diabetes research, particularly in protecting beta cells from immune attack. His work is vital for advancing treatments for diabetes and improving patient outcomes.

Latest Patents

Stephan Kissler holds a patent titled "Protection of Beta Cells from Immune Attack." This patent represents a crucial step in the development of therapies aimed at preserving insulin-producing cells in individuals with diabetes. He has 1 patent to his name, showcasing his innovative approach to addressing complex medical challenges.

Career Highlights

Kissler is affiliated with the Joslin Diabetes Center, Inc., a leading institution in diabetes research and care. His role at the center allows him to collaborate with other experts in the field and contribute to groundbreaking research that has the potential to change lives.

Collaborations

One of his notable collaborators is Peng Yi, with whom he has worked closely on various projects related to diabetes and immune response. Their partnership exemplifies the importance of teamwork in scientific research.

Conclusion

Stephan Kissler's contributions to diabetes research through his patent and work at the Joslin Diabetes Center highlight his commitment to improving health outcomes for individuals with diabetes. His innovative spirit and collaborative efforts continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…